Translating Scientific Evidence Into Practice Using Digital Medicine and Electronic Patient Reported Outcomes
Inflammatory Bowel Disease (IBD)
About this trial
This is an interventional prevention trial for Inflammatory Bowel Disease (IBD) focused on measuring IBD, Treat to target, Digital transformation network, Social determinants of health, e-PRO
Eligibility Criteria
Inclusion Criteria:
- Patients with confirmed Inflammatory Bowel Disease (IBD) will be enrolled into DTN in stepped-wedge cluster randomized trial
- Age greater than or equal to 18 years
- Ability to speak or understand English or Spanish Language.
Exclusion Criteria:
- Condition or disease that, in the opinion of the investigators, may make it exceedingly difficult for the patient to use DTN, including, but not limited to, advanced dementia.
Sites / Locations
- University of California, Davis
- Northwestern University
- RxHealth
- Icahn School of Medicine at Mount SinaiRecruiting
- Cleveland Clinic
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Digital Transformation Network (DTN) Program
Control Arm
IBD patients at the 3 sites will be sent a message to their Smartphone
Patients will enter the control group once they initially complete the ePRO and online assessment tools. They will remain in the control group, and then at set intervals each site will transition these patients into the DTN intervention arm.